In the February 2010 issue of Medical Device and Diagnostic Industry, the Editor’s write An Era of Change: New ­Director, New ­Direction for FDA?

Since his [CDRH Director Jeffrey Shuren, MD] appointment to acting director, Shuren has begun a comprehensive review of many programs and processes and set in motion a strategic planning process. He also prioritized the support of innovation in medical devices, the modernizing of device safety efforts, and the strengthening of important internal procedures.